Empowered Funds LLC Buys Shares of 543,548 Oscar Health, Inc. $OSCR

Empowered Funds LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) in the first quarter, HoldingsChannel reports. The firm purchased 543,548 shares of the company’s stock, valued at approximately $6,234,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quarry LP grew its stake in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the last quarter. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio acquired a new position in Oscar Health during the first quarter worth about $30,000. Fifth Third Bancorp lifted its holdings in shares of Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. Finally, Binnacle Investments Inc purchased a new stake in shares of Oscar Health in the second quarter valued at about $75,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Activity at Oscar Health

In related news, Director Mario Schlosser sold 880,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00. Following the sale, the director directly owned 480,866 shares of the company’s stock, valued at approximately $14,127,843.08. This trade represents a 64.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini sold 624,244 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the completion of the sale, the chief executive officer owned 7,751,570 shares of the company’s stock, valued at approximately $220,764,713.60. The trade was a 7.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 3,662,466 shares of company stock valued at $105,145,815. Insiders own 22.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on OSCR shares. Wolfe Research initiated coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company. Wells Fargo & Company set a $20.00 target price on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Weiss Ratings upgraded Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. UBS Group increased their target price on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Finally, Robert W. Baird raised their price target on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $22.00.

Oscar Health Stock Performance

NYSE OSCR opened at $31.33 on Friday. The business’s 50-day moving average price is $28.24 and its 200 day moving average price is $19.95. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.10. The company has a market capitalization of $9.45 billion, a PE ratio of -53.11, a price-to-earnings-growth ratio of 1.64 and a beta of 2.34. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm’s quarterly revenue was up 52.6% on a year-over-year basis. During the same period last year, the company earned $0.92 EPS. On average, research analysts predict that Oscar Health, Inc. will post 0.63 earnings per share for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.